The search strategy employed a blend of predetermined terms to maximize inclusivity and relevance as follows: (("Polypoidal Choroidal Vasculopathy" OR PCV) AND (Brolucizumab OR Beovu OR RTH-258 OR DLX 1008 OR S01LA06 OR "ESBA1008" OR Aflibercept OR "VEGF Trap-Regeneron" OR "VEGF Trap-Eye" OR EYLEA OR Zaltrap OR "AVE 0005" OR "AVE 005" OR ZIV-aflibercept OR "EYLEA HD" OR "Bay 86-5321" OR "BAY 865321")). This evidence concerns the gene VEGFA and Polypoidal choroidal vasculopathy.